PER 5.00% 10.5¢ percheron therapeutics limited

Ann: ATL1102 DMD Clinical Trial Application Submitted in Europe, page-27

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,164 Posts.
    lightbulb Created with Sketch. 563
    I think if we can get quite a few announcement updates in the near future, and I mean similar to one a week regarding this Trial Application Submission or anything else, it will really settle the nerves of everyone who, including myself aren't happy being considerably down on their investment. More announcements, more progression, better understanding, closer comms with us... rebuild the confidence.


 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.